Skip to main content
. 2017 Dec 23;9(7):7341–7358. doi: 10.18632/oncotarget.23641

Table 6. Gene set enrichment analysis results: Group 2.

ENRICHED IN GROUP 2 (GOOD OUTCOME)
GENESET NAME SIZE NOM p-val FDR q-val
LIM_MAMMARY_STEM_CELL_UP 41 0 0
LIU_PROSTATE_CANCER_DN 42 0 6.08E-04
SENESE_HDAC1_AND_HDAC2_TARGETS_DN 18 0 0.008256009
WANG_SMARCE1_TARGETS_UP 24 0 0.011867385
ONDER_CDH1_TARGETS_2_DN 32 0 0.013505637
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP 15 0 0.017456258
FORTSCHEGGER_PHF8_TARGETS_DN 18 0 0.022528453
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN 23 0.001287001 0.022527734
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN 29 0.001305483 0.040243994
CHANDRAN_METASTASIS_DN 15 0.001461988 0.02578634
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 33 0.002597403 0.05427582
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN 22 0.004166667 0.052254837
PASINI_SUZ12_TARGETS_DN 17 0.004279601 0.034044717
MARTINEZ_RB1_AND_TP53_TARGETS_UP 15 0.005763689 0.07122304
BRUINS_UVC_RESPONSE_LATE 27 0.006648936 0.06798041
JAEGER_METASTASIS_DN 22 0.008310249 0.06001583
CHICAS_RB1_TARGETS_CONFLUENT 33 0.008782936 0.07140977